This is an investigational study. Gemcitabine and clofarabine are FDA approved and commercially available for the treatment of lymphoma. Busulfan is FDA approved and commercially available for use in stem cell transplantation. The combination of gemcitabine given in combination with busulfan and clofarabine before an allogeneic stem cell transplant is investigational.